BALCO Medical Centre strengthens advanced cancer care in Central India focusing on complex surgeries: Our Bureau, Bengaluru ...
Neuberg Sehgal PathLab introduces advanced cytogenetics testing for comprehensive cancer diagnosis and prenatal screening: Our Bureau, Mumbai Wednesday, February 4, 2026, 17:30 Hr ...
Natera submits premarket approval to US FDA for Signatera CDx for detection of MRD in patients with muscle-invasive bladder cancer: Austin, Texas Wednesday, February 4, 2026, 18:0 ...
Himalaya Wellness launches nationwide stress awareness campaign; reveals women and young adults are most affected: Our Bureau, Bengaluru Wednesday, February 4, 2026, 17:45 Hrs [IS ...
Zydus receives US FDA tentative approval for dapagliflozin tablets, 5 mg and 10 mg: Our Bureau, Mumbai Wednesday, February 4, 2026, 17:05 Hrs [IST] Zydus Lifesciences Limited has ...
Truevis Technologies and Neusoft Medical Systems sign MoU for 300 radiology centres with SMC clinics: Our Bureau, Mumbai Wednesday, February 4, 2026, 17:15 Hrs [IST] Truevis Techn ...
Acurx Pharmaceuticals’ DNA Polymerase IIIC inhibitors receives US patent: Staten Island, New York Wednesday, February 4, 2026, 15:00 Hrs [IST] Acurx Pharmaceuticals, Inc., a lat ...
Aahwahan Foundation unveils India’s First Diabetic-Free Village Initiative in Nashik, Maharashtra: Our Bureau, Bengaluru Wednesday, February 4, 2026, 13:30 Hrs [IST] Aahwahan Fo ...
Joint statement on the renewed quadripartite MoU regarding cooperation on One Health until 2030: Geneva Wednesday, February 4, 2026, 17:00 Hrs [IST] Through the renewal of the Mem ...
Grace Cancer Foundation inks MoU with Government of Meghalaya, expands footprint to North East: Our Bureau, Bengaluru Wednesday, February 4, 2026, 15:30 Hrs [IST] Hyderabad-based ...
Care Health Insurance finds rising cancer treatment costs and long care cycles increase financial exposure in India: Our Bureau, Bengaluru Wednesday, February 4, 2026, 13:45 Hrs [ ...
AstraZeneca & Daiichi Sankyo’s Datroway granted Priority Review in US as 1st-line treatment for patients with metastatic TNBC who are not candidates for immunotherapy: Cambridge ...